Beta
Company data is growing.
← All companies
/
Top lists
/
Resmed
Resmed
2016–2025 · 469 US lab companies
2026-08-05
Overview
Earnings
Margins
Cash flow
Balance
Capital
Plot
USD millions
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
1 839
2 067
2 340
2 607
2 957
3 197
3 578
4 223
4 685
5 146
Operating profit (EBIT)
429
426
542
579
810
904
1 000
1 132
1 320
1 685
Net income attributable to shareholders
352
342
316
405
622
475
779
898
1 021
1 401
EBIT margin
23,3%
20,6%
23,2%
22,2%
27,4%
28,3%
28,0%
26,8%
28,2%
32,8%
Gross margin
58,0%
58,2%
58,2%
59,0%
58,1%
57,5%
56,6%
55,8%
56,7%
59,4%
Operating cash flow
548
414
505
459
802
737
351
693
1 401
1 752
Free cash flow
489
352
442
390
707
634
216
574
1 302
1 662
Cash
731
822
189
147
463
295
274
228
238
1 209
0
2 000
4 000
6 000
0,0%
10,0%
20,0%
30,0%
40,0%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
1 839
2 067
2 340
2 607
2 957
3 197
3 578
4 223
4 685
5 146
429
426
542
579
810
904
1 000
1 132
1 320
1 685